Labshake search
Citations for Tocris :
751 - 800 of 1039 citations for 3 4 Fluorophenyl 5 fluorobenzoic acid since 2020
Citations are collected from bioRxiv only, the total number of publications could be much larger.
-
bioRxiv - Molecular Biology 2024Quote: ... AML12 cells at 70% confluency were treated with 3 μM CHIR99021 (cat. no. 4423; Tocris) for 48h ...
-
bioRxiv - Neuroscience 2024Quote: ... each animal underwent 3 consecutive trials before and after treatment with prazosin (7.5mg/kg, Tocris Biosciences ...
-
bioRxiv - Cell Biology 2024Quote: ... 10 mM 3-methyladenine (3MA, diluted directly into cell culture medium at 10mM; Tocris, 3977), 2.5 µM brefeldin A (diluted from 25mM stock prepared in DMSO ...
-
bioRxiv - Cell Biology 2021Quote: ... B/D medium was supplemented during submerged culture with 1 nM EC23 (light-stable retinoic acid receptor agonist; Tocris, Abingdon, UK). After confluence was reached ...
-
bioRxiv - Neuroscience 2023Quote: ... Mice were injected intraperitoneally (i.p.) with 5.0mg/kg synthetic kainic acid (KA) dissolved in 0.9% saline (#7065, Tocris Bioscience, Bristol, United Kingdom). At twenty-minute intervals ...
-
bioRxiv - Neuroscience 2023Quote: ... one day of medium d10 (Medium d3–9 with 200 µM ascorbic acid [Sigma-Aldrich, A4403], 125 µM db-cAMP [Tocris, 1141] ...
-
bioRxiv - Neuroscience 2024Quote: ... Bilateral excitotoxic lesions of the dorsal striatum sub-regions (i.e. medial or lateral) were performed by injections of ibotenic acid (10mg/mL, Tocris, Bristol, UK) dissolved in a mixture of sterile NaCl (0.9% ...
-
bioRxiv - Pharmacology and Toxicology 2024Quote: ... Retinoic acid, BMS453 (RARβ agonist, CAS166977-43-1) and CD2665 (RARβ/γ antagonist, CAS 170355-78-9) were purchased from Tocris Biosciences (Bristol ...
-
bioRxiv - Neuroscience 2024Quote: ... cultures were maintained in neural maturation media [neural expansion media supplemented with 0.2 mM L-ascorbic acid (Tocris, 40-555-0), 20 ng/mL BDNF (R&D Systems ...
-
bioRxiv - Neuroscience 2021Quote: ... glutamate and GABA receptor blockers (10 μM NBQX, Tocris, UK, 1044; 5 μM CPP, Tocris, 0247; 5 μM SR-95531, Tocris, 1262; 1 μM CGP-55845, Tocris, 1248) were included in the recording solutions.
-
bioRxiv - Immunology 2021Quote: ... The non-selective MIF family cytokine inhibitor 4-IPP was obtained from Tocris Bioscience.
-
bioRxiv - Bioengineering 2024Quote: ... supplemented with 50 ng/mL bone morphogenetic protein 4 (BMP4; Tocris; 314-BP) and 100 ng/mL activin A (Tocris ...
-
bioRxiv - Cancer Biology 2023Quote: ... The N2/B27 medium was supplemented with 4 µM Dorsomorphin (Tocris, Cat # 3039) and 10 µM SB431542 (Tocris ...
-
bioRxiv - Neuroscience 2023Quote: ... MNI-glutamate (4 methoxy-7-nitroindolinyl caged L-glutamate) was purchased from Tocris Bioscience ...
-
bioRxiv - Neuroscience 2024Quote: ... to avoid polysynaptic recording and 10µM bicuculine (Tocris, CAS Number 485-49-4) by a 10 msec blue-light pulse at 0.1 Hz delivered through the 60X objective ...
-
bioRxiv - Pharmacology and Toxicology 2024Quote: ... 4-butoxy-N-(2,4-difluorophenyl)benzamide (VU0357121) was purchased from Tocris (Bristol, UK). [3H]methoxy-PEPy was custom synthesised by Pharmaron (Pharmaron ...
-
bioRxiv - Cell Biology 2024Quote: ... cells were either treated with vehicle (media) or 100nM Ex-4 (Tocris, 1933). After glucose starvation and pretreatment ...
-
bioRxiv - Neuroscience 2021Quote: ... The bath solution usually contained 6,7-dinitroquinoxaline-2,3-dione (DNQX, 10 µM) and D- aminophosphonovaleric acid (D-APV, 50 µM) to block ionotropic glutamate receptors (Tocris, Abingdon, United Kingdom). Patch electrodes had resistances of 4-6 MΩ when filled with KMeSO4- or CMeSO4-based internal solution (same as used in vivo) ...
-
bioRxiv - Immunology 2020Quote: ... These cells were then directed to become proepicardial cells by the addition of retinoic acid and WNT CHIR 99021 followed by TGFβ inhibition (SB431542, Tocris Bioscience 1614). Finally ...
-
bioRxiv - Neuroscience 2023Quote: ... and cells were centrifuged at 200 rcf for 5 min and resuspended in N2B27 with the same supplements as on day 0 except for the removal of Y27632 and addition of all-trans retinoic acid (100 nM; Tocris, 0695/50) and SAG (500 nM ...
-
bioRxiv - Neuroscience 2024Quote: ... or N-methyl-D-aspartic acid (NMDA) (final concentration 100 μM; 1 µL stock solution in PBS in 1 ml media 0114; Tocris, Abingdon, UK). A DMSO-only control was conducted for comparison with PTX ...
-
bioRxiv - Developmental Biology 2021Quote: ... NMP differentiation medium was supplemented with and 5 μM Y-27632 (Tocris).
-
bioRxiv - Cell Biology 2021Quote: Cells were treated with the actin inhibitor Cytochalasin-D (5 μM, Tocris), the Ezrin Inhibitor NSC668394 (50 μM ...
-
bioRxiv - Developmental Biology 2022Quote: ... cells were refreshed with BPEL supplemented with 5 μM XAV939 (Tocris Bioscience) and 50 ng/ml VEGF (R&D Systems) ...
-
bioRxiv - Physiology 2021Quote: ... SN-401 (DCPIB, 5 mg/kg of body weight/day, Tocris, D1540), SN-403 ...
-
bioRxiv - Developmental Biology 2021Quote: ... for 48 h followed by treatment with IWP2 (5 μM, Tocris, #3533) for an additional 48 h ...
-
bioRxiv - Cell Biology 2020Quote: ... media was changed to R/B-supplemented with 5 uM IWP2 (Tocris) for 48 hours ...
-
bioRxiv - Immunology 2021Quote: ... and 5 ng/ml IL-2 (carrier-free; Tocris R&D Systems) added with cells ...
-
bioRxiv - Bioengineering 2022Quote: ... and Nodal/Activin inhibitor (SB431542, Tocris, 1614, 5 µM, days 1-10). On day 2 ...
-
bioRxiv - Neuroscience 2022Quote: ... or 20 μM 2-methylthyo-adenosine-5’-triphosphate (2-MeSATP, Tocris, 1062) over a 5-min period ...
-
bioRxiv - Pharmacology and Toxicology 2023Quote: ... [d-Ala2,MePhe4,Gly (ol)5]enkephalin (DAMGO) was purchased from Tocris Bioscience (Minneapolis ...
-
bioRxiv - Neuroscience 2023Quote: ... was used to block GluN2A and ifenprodil (5 µM, Tocris, Cat#0545) was used to block GluN2B ...
-
bioRxiv - Neuroscience 2023Quote: ... The selective 5-HT2C receptor antagonist RS102221 (Tocris Bioscience, #1050, Minneapolis, MN) was dissolved in a 50% aCSF and 50% sterile saline solution and infused bilaterally into the aBNST at a dose of 0.5 µg per side [14][14] ...
-
bioRxiv - Systems Biology 2023Quote: ... 10 μM Forskolin (Fisher, BP2520-5) and 100 μM IBMX (Tocris, 2845). Cells were maintained in incubators at 37°C ...
-
bioRxiv - Bioengineering 2023Quote: ... and TGF-Beta inhibitor (SB431542, Tocris # 1614, 5 μM, days 0-7). Media was changed on days 3 and 6 and then every 2-3 days until day 7 ...
-
bioRxiv - Pharmacology and Toxicology 2023Quote: A CC-chemokine receptor 5 (CCR5) antagonist (maraviroc; Tocris Biosciences, Bristol, UK) was dissolved in dimethyl sulfoxide and diluted with sterile PBS for further use ...
-
bioRxiv - Cell Biology 2023Quote: ... Mitotic exit was induced by adding flavopiridol (Tocris Bioscience, 131740-09-5) to a final concentration of 20 µM ...
-
bioRxiv - Neuroscience 2024Quote: ... and 5 µM TGF-Beta Inhibitor (SB431542, Tocris # 1614, Days 0-18). Media changes occurred on Days 3 ...
-
bioRxiv - Neuroscience 2024Quote: ... The 5-HT2C receptor antagonist SB242084 (1 μM in 0.5 μL, Tocris) was dissolved in DMSO and diluted in saline (0.01% v/v DMSO) ...
-
bioRxiv - Neuroscience 2024Quote: ... EdU (10 μM) with or without the acetylcholine (0.5-5 μM, Tocris) was added and incubated for a further 24h ...
-
bioRxiv - Cell Biology 2024Quote: ... either with or without the additional supplementation of 5 nM T3 (Tocris), 100 nM sodium selenite (NaSe ...
-
bioRxiv - Developmental Biology 2020Quote: ... short-term serum-free culture was carried out in N2B27 supplemented with 3 μM CHIR99201 (Tocris), 1 μg/ml of Heparin (Sigma ...
-
bioRxiv - Developmental Biology 2020Quote: ... mTeSR Plus was replaced with the N2B27 basal medium supplemented with 3 μM CHIR99021 (Tocris Bioscience) and 40 ng/ml basic fibroblast growth factor bFGF/FGF2 (R&D Systems) ...
-
bioRxiv - Neuroscience 2020Quote: ... each disk with neurons was transferred into the physiological saline solution containing NBQX (3 μM, Tocris) and bicuculine (30 μM ...
-
Safety and efficacy of C9ORF72-repeat RNA nuclear export inhibition in amyotrophic lateral sclerosisbioRxiv - Systems Biology 2021Quote: ... supplemented with SMAD inhibitors (DMH-1 2 µM; SB431542-10 µM and CHIR99021 3 µM [ [Tocris]). The medium was changed every day for 6 days ...
-
bioRxiv - Neuroscience 2021Quote: ... 3-((±)2-carboxypiperazin-4yl) propyl-1-phosphate (CPP, NMDA receptor antagonist, 20 μM; Tocris Bioscience, UK) and 6-cyano-7-nitroquinoxaline-2,3-dione (CNQX ...
-
bioRxiv - Bioengineering 2021Quote: ... Plates were centrifuged at 100xg for 3 minutes in E8 medium containing 10 μM Y27632 (Tocris). The following day ...
-
bioRxiv - Neuroscience 2023Quote: ... KA (3 mg/mL) was prepared on the day of experimentation by dissolving KA (Tocris, 0222) in a 0.9% bacteriostatic saline solution ...
-
bioRxiv - Neuroscience 2023Quote: ... followed by seven days medium d3–9 (Medium d1-2 with 3 µM CHIR99021 [Tocris, 4423]), one day of medium d10 (Medium d3–9 with 200 µM ascorbic acid [Sigma-Aldrich ...
-
bioRxiv - Neuroscience 2023Quote: The neural activity was reversibly suppressed using the GABA-A agonist 4,5,6,7-tetrahydro isoxazole [5,4-c]-pyridine-3-ol (THIP hydrochloride; Tocris). The THIP was dissolved in phosphate-buffered saline (PBS) ...